尼氟滅酸

尼氟滅酸
臨床資料
AHFS/Drugs.com	國際藥品名稱
ATC碼	M01AX02 (WHO) M02AA17;
藥物動力學數據
生物半衰期	2.5 hr
識別資訊
	IUPAC命名法 2-{[3-(trifluoromethyl)phenyl]amino}nicotinic acid; ;
CAS號	4394-00-7
PubChem CID	4488;
IUPHAR/BPS	2439;
ChemSpider	4333 ;
UNII	4U5MP5IUD8;
KEGG	D08275 ;
ChEMBL	ChEMBL63323 ;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID1023368 ;
ECHA InfoCard	100.022.289
化學資訊
化學式	C13H9F3N2O2
摩爾質量	282.22 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
熔點	204 °C（399 °F）
	SMILES C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F;
	InChI InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20) ; Key:JZFPYUNJRRFVQU-UHFFFAOYSA-N ;

尼氟滅酸（英語：Niflumic acid；別名尼氟酸、氟尼酸）是一種治療關節和肌肉疼痛的藥物。它被歸類為環氧合酶-2的抑制劑。在實驗生物學中，尼氟滅酸也應用於抑制氯離子通道（英語：chloride channel）。^[2]還有報道稱，尼氟滅酸能夠作用於GABA-A^[3]及NMDA受體通道，^[4]並能阻滯T-型鈣離子通道。^[5]

參考資料

^ Half life. Drug Bank. [15 July 2011]. （原始內容存檔於2012-02-03）.
^ Knauf PA, Mann NA. Use of niflumic acid to determine the nature of the asymmetry of the human erythrocyte anion exchange system. The Journal of General Physiology. May 1984, 83 (5): 703–25. PMC 2215658  . PMID 6736917. doi:10.1085/jgp.83.5.703.
^ Sinkkonen ST, Mansikkamäki S, Möykkynen T, Lüddens H, Uusi-Oukari M, Korpi ER. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug. Molecular Pharmacology. September 2003, 64 (3): 753–63. PMID 12920213. doi:10.1124/mol.64.3.753.
^ Lerma J, Martín del Río R. Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation. Molecular Pharmacology. February 1992, 41 (2): 217–22. PMID 1371581.
^ Balderas E, Ateaga-Tlecuitl R, Rivera M, Gomora JC, Darszon A. Niflumic acid blocks native and recombinant T-type channels. Journal of Cellular Physiology. June 2012, 227 (6): 2542–55. PMC 4146346  . PMID 21898399. doi:10.1002/jcp.22992.

[1] Half life. Drug Bank. [15 July 2011]. （原始內容存檔於2012-02-03）.

[2] Knauf PA, Mann NA. Use of niflumic acid to determine the nature of the asymmetry of the human erythrocyte anion exchange system. The Journal of General Physiology. May 1984, 83 (5): 703–25. PMC 2215658  . PMID 6736917. doi:10.1085/jgp.83.5.703.

[3] Sinkkonen ST, Mansikkamäki S, Möykkynen T, Lüddens H, Uusi-Oukari M, Korpi ER. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug. Molecular Pharmacology. September 2003, 64 (3): 753–63. PMID 12920213. doi:10.1124/mol.64.3.753.

[4] Lerma J, Martín del Río R. Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation. Molecular Pharmacology. February 1992, 41 (2): 217–22. PMID 1371581.

[5] Balderas E, Ateaga-Tlecuitl R, Rivera M, Gomora JC, Darszon A. Niflumic acid blocks native and recombinant T-type channels. Journal of Cellular Physiology. June 2012, 227 (6): 2542–55. PMC 4146346  . PMID 21898399. doi:10.1002/jcp.22992.

[2]

[3]

[4]

[5]

[1]